Anti-androgenic activities of Ganoderma lucidum

Journal of Ethnopharmacology

Volumn 102, Issue 1, 2005, Pages 107-112

  Fujita, Rumi ^a   Liu, Jie ^a   Shimizu, Kuniyoshi ^a   Konishi, Fumiko ^b   Noda, Kiyoshi ^b   Kumamoto, Shoichiro ^b   Ueda, Chie ^c   Tajiri, Hisatoshi ^c   Kaneko, Shuhei ^d   Suimi, Yoshitaro ^e   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Chlorella Industry Co Ltd   (Japan)

^c Yamaya Conmunications Co Ltd   (Japan)

^d Forestry and Forest Products Research Institute   (Japan)

^e Bisoken and Co Ltd   (Japan)

Author keywords

5 Reductase; Anti androgen activities; Benign prostatic hyperplasia (BPH); Ganoderma lucidum; Ganodermataceae

Indexed keywords

ANTIANDROGEN; GANODERMA LUCIDUM EXTRACT; PLANT EXTRACT; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GANODERMA LUCIDUM; MALE; NONHUMAN; PROSTATE; RAT;

ANDROGEN ANTAGONISTS; ANIMALS; CHOLESTENONE 5 ALPHA-REDUCTASE; FEMALE; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, SPRAGUE-DAWLEY; REISHI;

BASIDIOMYCOTA; GANODERMA LUCIDUM; GANODERMATACEAE;

EID: 25444516274     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2005.05.041     Document Type: Article

References (26)

1. S. Andersson, and D.W. Russell Structural and biochemical-properties of cloned and expressed human and rat steroid 5α-reductases Proceedings of the National Academy of Sciences of the United States of America 87 1990 3640 3644
2. G. Barrtsch, R.S. Rittmaster, and H. Klocker Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia European Urology 37 2000 367 380
3. G. Barrtsch, R.S. Rittmaster, and H. Klocker Dihydrotestosterone and the concept of 5α-reductase inhibition on human benign prostatic hyperplasia World Journal of Urology 19 2002 413 425
4. H. Bonkhoff, U. Stein, G. Aumuller, and K. Remberger Differential expression of 5α-reductase isoenzymers in the human prostate and prostatic carcinomas Prostate 29 1996 261 267
5. A. de la Taille, O.R. Hayek, M. Burchardt, T. Burchardt, and A.E. Katz Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports Journal of Alternative and Complementary Medicine (New York, N.Y.) 6 2000 449 451
6. R.S. DiPaola, H. Zhang, G.H. Lambert, R. Meeker, E. Licitra, M.M. Rafi, B.T. Zhu, H. Spaulding, S. Goodin, M.B. Toledano, W.N. Hait, and M.A. Gallo Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer New England Journal of Medicine 339 1998 785 787
7. D.M. Eisenberg, R.B. Davis, S.L. Ettner, S. Appel, S. Wilkey, M. VanRompay, and R.C. Kessler Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey, JAMA Journal of the American Medical Association 280 1998 1569 1575
8. 1 adrenoceptor antagonistic and steroid 5α-reductase inhibitory actions; pharmacological properties in vivo The Journal of Pharmacology and Experimental Therapeutics 290 1999 1013 1018
9. E. Giovannucci, M.J. Stampfer, and K. Krithivas The CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proceedings of the National Academy of Sciences of the United States of America 94 1997 3320 3323
10. A. Graul, J. Silvestre, and J. Castaner Dutasteride: steroid 5α-reductase inhibitor treatment of BPH Drugs of the Future 24 1999 246 253
11. A.W. Hsing, J.K. Reichardt, and F.Z. Stanczyk Hormones and prostate cancer: current perspectives and future directions Prostate 52 2002 213 235
12. C. Iehle, F. Radvanyi, S. Gil Diez de Medina, L.H. Ouafik, H. Gerard, D. Chopin, J.P. Raynaud, and P.M. Martin Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissue Journal of Steroid Biochemistry and Molecular Biology 68 1999 189 195
13. J. Imperato-McGinley, B. Sanchez, and E.D. Vaughan Comparison of the effects of the 5α-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies Endocrinology 131 1992 1149 1156
14. E.P. Jenkins, C.L. Hsieh, A. Milatovitch, K. Normington, D.M. Berman, U. Francke, and D.W. Russell Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homolog Genomics 11 1991 1102 1112
15. J.H. Jian, V. Slivova, T. Valachovicova, K. Harvey, and D. Sliva Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostatae cancer cells PC-3 International Journal of Oncology 24 2004 1093 1099
16. B.S. Min, J.J. Gao, N. Nakamura, and M. Hattori Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells Chemical and Pharmaceutical Bulletin 48 2000 1026 1033
17. T. Mizuno, G.Y. Wang, J. Zhang, H. Kawagishi, T. Nishitoba, and J. Li Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects Food Review International 11 1995 151 166
18. Y. Mizushina, L. Hanashima, T. Yamaguchi, M. Takemura, F. Sugawara, M. Saneyoshi, A. Matsukage, S. Yoshida, and K. Sakaguchi A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases Biochemical and Biophysical Research Communications 249 1998 17 22
19. R.K. Ross, L. Bernstein, and R.A. Lobo 5α-Reductase activity and risk of prostate cancer among Japanese and US white and black males Lancet 339 1992 887 889
20. D.W. Russell, and J.D. Wilson Steroid 5α-reductase: two genes/two enzymes Annual Review of Clinical Biochemistry 63 1994 25 61
21. K. Shimizu, M. Fukuda, R. Kondo, and K. Sakai The 5α-reductase inhibitory components from heartwood of Artocarpus incisus: structure-activity investigations Planta Medica 66 2000 16 19
22. A.E. Thigpen, K.M. Cala, and D.W. Russell Characterization of Chinese hamster on vary cell lines expressing human steroid 5α-reductase isozymes Journal of Biological Chemistry 268 1993 17404 17412
23. I.M. Thompson, J. Phyllis, P.J. Goodman, C.M. Tangen, M. Scott Lucia, G.J. Miller, L.G. Ford, M.M. Lieber, and R. Duane Cespedes The influence of finasteride on the development of prostate cancer The New England Journal of Medicine 349 2003 215 224
24. M.C. Uygur, E. Gur, A.I. Ariki, U. Altug, and D. Erol Erectile dysfunction following treatments of benign prostatic hyperplasia: a prospective study Andrologia 30 1998 5 10
25. S.P. Wasser, and A.L. Weis Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective Critical Reviews Immunology 19 1999 65 96
26. T.K. Yun Update from Asia. Asian studies on cancer chemoprevention Annals of the New York Academy of Sciences 889 1999 157 192